Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance
ISTANBUL escrs









Take a look inside the London 2014 Congress

video-icon

Then register to join us
in Barcelona!





Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Quality of life outcomes with the WaveLight Refractive Suite (Excimer EX500 and Femtosecond FS200 lasers)

Poster Details

First Author: A.Cummings IRELAND

Co Author(s):    M. Maus   D. Durrie   M. Gordon   R. Williams   J. Gow        

Abstract Details

Purpose:

To evaluate quality of life outcomes with LASIK treatments for myopia using the WaveLight Refractive Suite.

Setting:

Prospective, post-market, and open label trial at 4 sites, 2 each in US and Europe

Methods:

Myopic subjects 18 years of age or older underwent LASIK treatment with the WaveLight Refractive Suite. Subjects with myopia up to – 12 D sphere and 6 D cylinder were eligible. Subjects completed visits at screening, 1 day, 1 month, 3 months, and 6 months postoperatively. Quality of life was evaluated with the Refractive Status and Vision Profile (RSVP) questionnaire. Questions 3, 10 and 17 of the RSVP questionnaire were evaluated.

Results:

97 subjects underwent LASIK treatment and 96 subjects were included in the full analysis set. For question 3, 100% of subjects did not wear glasses or contact lenses at 6 months compared to 1% at screening. For question 10, on a 0 to 10 scale, the mean score for vision over the past 4 weeks with no glasses or contact lenses was 3.6 (1.71) at baseline and 9.4 (0.78) at 6 months. For the question 17, “I worry about my vision”, a response of “never” was reported by 10.4% and 52.6% of subjects at baseline and 6 months respectively.

Conclusions:

At 6 months postoperatively, all subjects did not wear glasses or contact lenses for distance vision, subjects had an improvement in their vision compared to the screening visit, and more subjects never worried about their vision compared to baseline.

Financial Disclosure:

One or more of the authors is employed by a for-profit company with an interest in the subject of the presentation, One or more of the authors receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented

Back to Poster listing